Covered recipient · General Payments record
ASHLEY NICOLE FLENER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,114.64
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $404.98 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $209.96 | 17 |
| ABBVIE INC. | $69.25 | 4 |
| Amgen Inc. | $31.91 | 2 |
| GlaxoSmithKline, LLC. | $29.34 | 2 |
| Janssen Pharmaceuticals, Inc | $19.74 | 1 |
| DEXCOM, INC. | $16.05 | 1 |
| Lilly USA, LLC | $14.86 | 1 |
| Acerta Pharma LLC | $13.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.77 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110945 | CMS |
| ABBVIE INC. | $14.34 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110947 | CMS |
| ABBVIE INC. | $17.81 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110949 | CMS |
| ABBVIE INC. | $16.33 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110951 | CMS |
| Amgen Inc. | $13.48 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115626254 | CMS |
| Amgen Inc. | $18.43 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117554225 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.87 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104253881 | CMS |
| Dexcom, Inc. | $16.05 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153350600 | CMS |
| GlaxoSmithKline, LLC. | $13.24 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116638454 | CMS |
| GlaxoSmithKline, LLC. | $16.10 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116315528 | CMS |
| Janssen Pharmaceuticals, Inc | $19.74 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078026286 | CMS |
| Lilly USA, LLC | $14.86 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135580566 | CMS |
| Novo Nordisk Inc | $15.50 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100450946 | CMS |
| Novo Nordisk Inc | $13.29 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100469124 | CMS |
| Novo Nordisk Inc | $15.18 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100531921 | CMS |
| Novo Nordisk Inc | $13.34 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100229056 | CMS |
| Novo Nordisk Inc | $8.20 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100598223 | CMS |
| Novo Nordisk Inc | $14.01 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100628124 | CMS |
| Novo Nordisk Inc | $13.11 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100345382 | CMS |
| Novo Nordisk Inc | $17.98 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100255256 | CMS |
| Novo Nordisk Inc | $7.79 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100317016 | CMS |
| Novo Nordisk Inc | $12.28 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100332288 | CMS |
| Novo Nordisk Inc | $7.50 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100588457 | CMS |
| Novo Nordisk Inc | $12.70 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100249758 | CMS |
| Novo Nordisk Inc | $8.56 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100329080 | CMS |
| Novo Nordisk Inc | $11.11 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100577474 | CMS |
| Novo Nordisk Inc | $17.45 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100420166 | CMS |
| Novo Nordisk Inc | $13.03 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100461154 | CMS |
| Novo Nordisk Inc | $8.93 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100296703 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.